Background: The COVID-19 pandemic disrupted routine osteoporosis care due to clinic closures and limited in-person consultations. Telehealth emerged as an alternative model enabling remote care delivery and monitoring. However, previous reviews on telehealth either did not include the pandemic period or had a limited focus in scope. Evidence synthesized specifically for osteoporosis care during the pandemic is needed but lacking. Methods: We systematically searched PubMed, MEDLINE, EMBASE, PsycINFO, Web of Science, and CINAHL for studies on telehealth for osteoporosis published between January 2021 and March 2023. Five studies met the inclusion criteria of: osteoporosis population, telehealth intervention, and COVID-19 pandemic timeframe. Data was extracted on study characteristics, COVID-19 outcomes, osteoporosis status, telehealth purpose, patient satisfaction, and clinical outcomes. Result: The five studies showed telehealth was used for monitoring data, delivering test results, adjusting medications, and assessments. Osteoporosis prevalence among telehealth users ranged 30-100%. High patient satisfaction was reported with telehealth versus in-person care. No major differences occurred in medication delays or fractures between telehealth and in-person groups. Conclusion: This review found telehealth enables effective osteoporosis care and monitoring during the pandemic, with high patient and provider satisfaction. However, more robust randomized controlled trials are needed to establish stronger evidence around telehealth's impacts on clinical osteoporosis outcomes. Implications: Though promising, further high-quality studies will help clarify telehealth's role in improving osteoporosis care and outcomes. Findings inform guidelines on integrating telehealth into routine management. Evidence on user perspectives optimizes telehealth implementation policies.

Given the limited access to medical facilities, impeding lockdown, and social isolation during the COVID-19 pandemic, an upsurge in postpartum depression among pregnant mothers in their puerperal period has become more apparent alongside an eventual increase in suicidal behavior. This article aimed to discuss the crucial aspects of different clinical case studies treated during recent periods throughout the COVID-19 pandemic via teleconsultations. We hoped to demonstrate tremendous opportunities for the application of healthcare via therapeutic tools online in telemedicine to manage such conditions in a developing country like Bangladesh with a severe scarcity of healthcare infrastructure and resources.

Online shopping is a growing phenomenon and social media namely Facebook has radically changed consumers online purchase behaviour; especially the interactive information system of consumers, peers, and vendors. Similar to other online purchasing products or services, e-cigarette marketing in Facebook has potential. This study aims to determine the association between individual’s online interaction and e-cigarette purchase intention from Facebook vape groups. A cross-sectional study was conducted among 214 respondents using the Facebook platform from September to December 2019. Data were collected via a self-administered questionnaire. The Chi-square test was used for data analyses using SPSS (version 25.0). Most of the participants were male; the mean age of the respondents was 27.41 ± 2.1. Total 93.9% (201 of 214) and 56.1% (120 of 214) respondents were vaper and smoker respectively. Among the non-smokers, most of the respondents were vaper (84 of 94, 89.4%). Consumers smoking and vaping status were associated with each other (χ2 = 6.11, P=0.01). There was an association between vaping status and purchase intention of e-cigarettes from the Facebook vape group (χ2 = 5.06, P=0.02). Online interactions, namely like (χ2 = 5.88, P <0.01), post (χ2 = 7.16, P <0.01) and sharing (χ2 = 10.14, P <0.01) of the e-cigarette related information or advertisements in social media were associated with purchase intention of e-cigarettes from Facebook vape group. This study revealed individuals vaping and online interactions were associated with an online purchase the intention of e-cigarette in Facebook. Public health researchers and policymakers might contemplate the regulatory environment of online marketing of e-cigarettes to curtail the uptake of e-cigarettes among non-smokers.

The popularity of e-cigarette is growing worldwide. Its health hazards and role in smoking cessation is controversial. There is no doubt that health care professionals can play a vital role in assisting patients who wish to use e-cigarettes to quit smoking but there is a gap in the evidence. The present study aimed to reveal the perception of e-cigarettes as a quit smoking tool and its health hazards among physicians in Bangladesh. A cross-sectional study was conducted by means of a survey via self-administered structured questionnaires in Bangladesh. Data was collected from September 2019 to February 2020 and analysed by descriptive frequency and chi-square test using SPSS. A total of 145 physicians have participated in this study, 88.9% provided professional advice on quit smoking to their patients. Total 51.7%, 51.9%, 41.3%, 52.4%, 42.8%, and 47.6% physicians mentioned that e-cigarettes may cause throat irritations, cough, headache, dryness of mouth, cardiovascular disease, and cancer respectively. Chi-square test revealed that there is no association between a physician’s professional advice for quit smoking and perception of e-cigarettes as a smoking cessation tool. The physician’s perception of e-cigarettes is crucial for reducing any type of tobacco consumption. Evidence based e-cigarette related public health intervention for physicians are required to mitigate the use of e-cigarette to quit smoking.